| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 135.41 | 17.6% | 9.0% |
| Total Income | 149.97 | 24.3% | 3.8% |
| Expenditure | 116.26 | 21.7% | 12.3% |
| PBT | 33.70 | 34.3% | 44.6% |
| Net Profit | 25.17 | 33.1% | 42.3% |
| OPM | 16.25% | 2.17pp | 4.32pp |
| NPM | 16.79% | 1.12pp | 5.43pp |
| EPS | 0.27 | 17.4% | 68.8% |
Syncom Formulations: FY26 Revenue ₹486.57 Mn
22 May 2026 · 22 May, 6:42 pm
Summary
SYNCOM FORMULATIONS (INDIA) LIMITED reported robust financial results for both the quarter and the full financial year ended March 31, 2026. The company's revenue from operations for the full financial year increased by 5.12% year-on-year to ₹48,657.28 Lacs, with profit for the year surging by 55.51% to ₹7,600.80 Lacs. Performance in the fourth quarter was particularly strong, with revenue from operations growing by 29.56% year-on-year to ₹14,846.33 Lacs and quarterly profit rising by 40.41% to ₹2,457.42 Lacs. The financial statements received an unmodified Auditors' Report, indicating a clean audit opinion.
Key Highlights
- 1
SYNCOM FORMULATIONS (INDIA) LIMITED achieved a revenue from operations of ₹48,657.28 Lacs for the financial year ended March 31, 2026, representing a 5.12% increase year-on-year.
- 2
The company's profit for the financial year ended March 31, 2026, significantly grew by 55.51% to ₹7,600.80 Lacs, up from ₹4,887.18 Lacs in the prior fiscal year.
- 3
For the fourth quarter ended March 31, 2026, revenue from operations recorded a substantial 29.56% year-on-year growth, reaching ₹14,846.33 Lacs.
- 4
Profit for Q4 FY26 demonstrated a strong increase of 40.41% year-on-year, totaling ₹2,457.42 Lacs.
- 5
Basic earnings per equity share for continuing operations improved to ₹0.62 for FY26 compared to ₹0.39 in FY25.
- 6
Total comprehensive income for FY26 stood at ₹7,240.07 Lacs, reflecting growth from ₹5,345.20 Lacs in FY25.
Informational and educational content only. Not investment advice.